| Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection C Phetsouphanh, DR Darley, DB Wilson, A Howe, CML Munier, SK Patel, ... Nature immunology 23 (2), 210-216, 2022 | 934 | 2022 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 391 | 2021 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 175 | 2022 |
| SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants F Tea, A Ospina Stella, A Aggarwal, D Ross Darley, D Pilli, D Vitale, ... PLoS medicine 18 (7), e1003656, 2021 | 140 | 2021 |
| SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, A Akerman, V Milogiannakis, MR Silva, G Walker, AO Stella, ... EBioMedicine 84, 2022 | 95 | 2022 |
| Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection DR Darley, GJ Dore, L Cysique, KA Wilhelm, D Andresen, K Tonga, ... The Medical Journal of Australia 214 (6), 279, 2021 | 67 | 2021 |
| SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, AO Stella, G Walker, A Akerman, V Milogiannakis, F Brilot, ... medrxiv, 2021.12. 14.21267772, 2021 | 66 | 2021 |
| Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia A Aggarwal, AO Stella, G Walker, A Akerman, C Esneau, V Milogiannakis, ... Nature Microbiology 7 (6), 896-908, 2022 | 43 | 2022 |
| The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC LA Cysique, D Jakabek, SG Bracken, Y Allen‐Davidian, B Heng, S Chow, ... Annals of Clinical and Translational Neurology 10 (8), 1338-1352, 2023 | 28 | 2023 |
| Emergence and antibody evasion of BQ, BA. 2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level A Akerman, V Milogiannakis, T Jean, C Esneau, MR Silva, T Ison, ... EBioMedicine 90, 2023 | 28 | 2023 |
| Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study LA Cysique, D Jakabek, SG Bracken, Y Allen-Davidian, B Heng, S Chow, ... Medrxiv, 2022.06. 07.22276020, 2022 | 28 | 2022 |
| Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: a systematic review HE Braithwaite, DR Darley, J Brett, RO Day, JE Carland Transplantation Reviews 35 (2), 100610, 2021 | 28 | 2021 |
| Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort DR Darley, GJ Dore, AL Byrne, ML Plit, BJ Brew, A Kelleher, GV Matthews ERJ Open Research 7 (4), 2021 | 26 | 2021 |
| Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation—a retrospective single‐center cohort … DR Darley, J Ma, E Huszti, P Fiset, L Levy, DM Hwang, P Pal, W Klement, ... Transplant International 34 (1), 62-75, 2021 | 25 | 2021 |
| Practices of therapeutic drug monitoring in tuberculosis: an international survey I Margineanu, O Akkerman, D Cattaneo, D Goletti, DJE Marriott, ... The European Respiratory Journal 59 (4), 2102787, 2022 | 24 | 2022 |
| Surveillance bronchoscopy: is it still relevant? M Benzimra Seminars in Respiratory and Critical Care Medicine 39 (02), 219-226, 2018 | 17 | 2018 |
| High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells C Phetsouphanh, WH Khoo, K Jackson, V Klemm, A Howe, A Aggarwal, ... Frontiers in immunology 13, 1032911, 2022 | 15 | 2022 |
| Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection C Phetsouphanh, B Jacka, S Ballouz, KJL Jackson, DB Wilson, ... Nature Communications 15 (1), 3315, 2024 | 14 | 2024 |
| Approaches to the management of sensitized lung transplant candidates: findings from an international survey M Aversa, DR Darley, A Hirji, L Snyder, D Lyu, F Parquin, M Perch, ... The Journal of Heart and Lung Transplantation 39 (4), S315, 2020 | 14 | 2020 |
Gail MatthewsKirby Institute, University of New South Walesכתובת אימייל מאומתת בדומיין kirby.unsw.edu.au
